Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Halothane hepatitis

J Neuberger1

  • 1Queen Elizabeth Hospital, Birmingham, UK. j.m.neuberger@bham.ac.uk

European Journal of Gastroenterology & Hepatology
|September 23, 1998
PubMed
Summary
This summary is machine-generated.

Halothane anesthesia can cause rare but severe liver failure (halothane hepatitis). Strict adherence to guidelines can minimize, but not eliminate, these immune-mediated adverse drug reactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect on consent rates for deceased organ donation in Wales after the introduction of an opt-out system.

Anaesthesia·2020
Same author

Editorial: covert hepatic encephalopathy-silent but serious.

Alimentary pharmacology & therapeutics·2018
Same author

Confirmation of specificity of reactivity in a solid phase ELISA for the detection of hepatitis E viral antigen improves utility of the assay.

Journal of virological methods·2017
Same author

Donors With Immune Thrombocytopenia: Do They Pose a Risk to Transplant Recipients?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis.

Alimentary pharmacology & therapeutics·2016
Same author

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same journal

Comment on 'Associations between 12 insulin resistance surrogates with metabolic dysfunction-associated steatotic liver disease risk and all-cause mortality: data from the National Health and Nutrition Examination Survey III (1988-1994)'.

European journal of gastroenterology & hepatology·2026
Same journal

Alarm symptoms at diagnosis of coeliac disease and long-term outcomes.

European journal of gastroenterology & hepatology·2026
Same journal

Artificial intelligence-integrated nanotherapeutics for rare Peutz-Jeghers syndrome hamartoma-induced obstructions: latest clearance strategies.

European journal of gastroenterology & hepatology·2026
Same journal

'Presence of alarm symptoms at coeliac disease diagnosis is not associated with poorer long-term treatment outcomes' [Letter].

European journal of gastroenterology & hepatology·2026
Same journal

Atrial fibrillation in patients with alcohol-associated hepatitis leads to increased mortality.

European journal of gastroenterology & hepatology·2026
Same journal

Association between albumin-bilirubin score, model for end-stage liver disease score, platelet-albumin-bilirubin score, and acute-on-chronic liver failure complications: a cross-sectional study in a Chinese population.

European journal of gastroenterology & hepatology·2026
See all related articles

Area of Science:

  • Anesthesiology
  • Hepatology
  • Immunology

Background:

  • Halothane is an effective anesthetic agent with a rare risk of fulminant hepatic failure.
  • Halothane hepatitis is an immune-mediated adverse drug reaction.
  • Existing guidelines aim to reduce halothane hepatitis incidence, but cases persist.

Purpose of the Study:

  • To review the incidence and mechanisms of halothane hepatitis.
  • To emphasize the importance of adherence to established guidelines.
  • To discuss the implications for managing immune-mediated adverse drug reactions.

Main Methods:

  • Review of existing literature on halothane hepatitis.
  • Analysis of reported cases and guideline adherence.
  • Discussion of proposed immunological mechanisms.

Related Experiment Videos

Main Results:

  • Halothane hepatitis, though rare, continues to occur despite guidelines.
  • Non-adherence to guidelines contributes to persistent cases.
  • No specific treatments exist for established halothane hepatitis; liver transplantation may be necessary.

Conclusions:

  • Stricter adherence to halothane administration guidelines is crucial to reduce, but not eliminate, hepatitis cases.
  • Halothane hepatitis serves as a model for understanding immune-mediated adverse drug reactions.
  • The mechanism involves sensitization to autoantigens like CYP2D6 and altered liver cell determinants.